Polydrug Abuse (eBook)

Front Cover 1
Polydrug Abuse: The Results of a National Collaborative Study 4
Copyright Page 5
Table of Contents 8
Dedication 6
List of Contributors 14
Foreword 18
Acknowledgments 22
CHAPTER I. Introduction 28
An Overview of the Population Studied 34
Methods of Classifying Polydrug Abusers 34
Social Cost 38
Visability of the Patient Population 38
PART 1: Classification and Description of the Polydrug Users 42
Editors' Introduction 42
CHAPTER II. Referral Sources and Outreach: Critical Variables in Understanding the Polydrug-Abusing Sample 44
Differential Psychosocial Characteristics Related to Referral Source 45
CHAPTER III. Nonpatient Polydrug Users 58
Method 59
Results 73
Discussion 83
CHAPTER IV. Female Polydrug Abusers 86
Rationale Offered for Sex-Linked Differences in Drug Use Patterns 89
Data on Psychoactive Drug Use and Abuse 91
Subpopulations of Female Population 96
Discussion 118
Conclusions 121
CHAPTER V. Two Typologies of Polydrug Abusers 124
Streetwise and Self-Medication Dimensions 132
Sex and Streetwise Orientation 150
Summary 152
CHAPTER VI. An Empirical Typology of Multiple Drug Abusers 156
Method 158
Results 159
Discussion 172
CHAPTER VII. Dimensions of Polydrug Abuse: An MMPI Study 176
Classes of Substance Abusers 176
Study Sample 184
Discussion 203
PART 2: Epidemiology 208
Editors' Introduction 208
CHAPTER VIII. Incidence of First Use of Nonopiate Drugs: Inferences from Current Data 210
Sampling Problems: The Selectivity of Incidence Data 212
Interpretation of Incidence Data: Its Relationship to Drug Abuse 212
Empirical First-Use Data from Treatment Programs 214
Which Drugs Are Most Abused? 215
Histories of Misuse: Temporal Sequences and Micro-demographic Differences in Peak Onset 226
The Progression Hypothesis: Inferences from Incidence Analysis 227
Conclusions 235
A Definitive Incidence Study 236
CHAPTER IX. Three National Estimates of Prevalence of Nonopiate Drug Abuse 238
The "Alcoholism" Method 239
Comparison Survey Method 241
Discussion 245
PART 3: Central Nervous System Consequences of Polydrug Abuse 246
Editors' Introduction 246
CHAPTER X. Neuropsychological Effects of Polydrug Abuse 250
Introduction 250
Method 260
Results 267
Three-Month Follow-Up Evaluation Results 279
Discussion 282
CHAPTER XI. Neuropsychological Impairment and Psychopathology 290
Method 291
Literature Review 292
Results 293
CHAPTER XII. Comparison of Results from Serially Collected Neuropsychological and EEG Data 300
Methodology 304
Results 307
Comparison of Halstead-Retain Data with That Obtained by Compressed Spectral Analysis of the EGG 318
Comment 321
CHAPTER XIII. Sleep Patterns of Abusers during Titration and Withdrawal from Methaqualone or Secobarbital 326
Method 332
Results 334
Discussion 346
PART 4: Impact of Polydrug Abuse on Nondrug Abuse Health Delivery System 350
Editors' Introduction 350
CHAPTER XIV. Physician Attitudes Concerning Drug Abuse Treatment 352
Some Field Observations 354
Physician Opinion Survey 354
Data Analysis 355
Therapeutic Pessimism Scale 355
Needs in Drug Abuse as Perceived by Physicians 361
Discussion and Summary 361
CHAPTER XV. Response of Traditional Health Care Agencies to Nonopiate Abusers 364
Methodology 365
Results 368
Discussion 379
PART 5: Conclusions and Recommendations 384
Editors' Introduction 384
CHAPTER XVI. Some Observations on Collaborative Data Management 386
Collaborative Research Projects 386
Sampling Considerations 387
The Collaborative Group Process 387
Step Funding 388
Data-Related Issues 388
The Importance of Record Design 391
The Master File 392
Master File Planning 393
The Data Flow 394
In Closing 397
CHAPTER XVII. Conclusions and Recommendations for Future Research 398
References 402
Subject Index 420